These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 9293458

  • 1. Treatment results in children and adolescents with loco-regional recurrences of abdominal germ cell tumors (GCTs): a pilot-study with PEI chemotherapy and regional deep hyperthermia (RHT) in comparison to a matched cohort.
    Wessalowski R, Blohm M, Calaminus G, Engert J, Harms D, Krause I, Kruck H, Grüttner HP, Pape H, Göbel U.
    Klin Padiatr; 1997; 209(4):250-6. PubMed ID: 9293458
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U, Bamberg M, Engert J, Gnekow AK, Haas HJ, Jürgens H, Kühl J, Lenard HG, Lumenta C, Niethammer D.
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [Abstract] [Full Text] [Related]

  • 3. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G, Bamberg M, Jürgens H, Kortmann RD, Sörensen N, Wiestler OD, Göbel U.
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [Abstract] [Full Text] [Related]

  • 4. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
    Wessalowski R, Schneider DT, Mils O, Friemann V, Kyrillopoulou O, Schaper J, Matuschek C, Rothe K, Leuschner I, Willers R, Schönberger S, Göbel U, Calaminus G, MAKEI study group.
    Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
    [Abstract] [Full Text] [Related]

  • 5. Hyperthermia for the treatment of patients with malignant germ cell tumors: a phase I/II study in ten children and adolescents with recurrent or refractory tumors.
    Wessalowski R, Kruck H, Pape H, Kahn T, Willers R, Göbel U.
    Cancer; 1998 Feb 15; 82(4):793-800. PubMed ID: 9477114
    [Abstract] [Full Text] [Related]

  • 6. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U, Calaminus G, Teske C, Bamberg M, Bökkerink JP, Haas RJ, Holschneider AM, Janka-Schaub G, Jürgens H, Mittler U.
    Klin Padiatr; 1993 Feb 15; 205(4):231-40. PubMed ID: 7690864
    [Abstract] [Full Text] [Related]

  • 7. An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors.
    Wessalowski R, Schneider DT, Mils O, Hannen M, Calaminus G, Engelbrecht V, Pape H, Willers R, Engert J, Harms D, Göbel U.
    Klin Padiatr; 2003 Feb 15; 215(6):303-9. PubMed ID: 14677093
    [Abstract] [Full Text] [Related]

  • 8. Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.
    Issels RD, Bosse D, Abdel-Rahman S, Starck M, Panzer M, Jauch KW, Stiegler H, Berger H, Sauer H, Peter K.
    Cancer Chemother Pharmacol; 1993 Feb 15; 31 Suppl 2():S233-7. PubMed ID: 8453705
    [Abstract] [Full Text] [Related]

  • 9. [Non-testicular germ cell tumors: analysis of the therapy study MAKEI 83/86 anc changes in the protocol for the follow-up study].
    Göbel U, Bamberg M, Haas RJ, Bökkerink JP, Brämswig G, Calaminus G, Engert J, Gadner H, Havers W, Janka-Schaub GE.
    Klin Padiatr; 1989 Feb 15; 201(4):247-60. PubMed ID: 2476583
    [Abstract] [Full Text] [Related]

  • 10. [Intracranial germ cell tumors: analysis of the therapy study MAKEI 83/86 and changes in protocol for the follow-up study].
    Göbel U, Bamberg M, Budach V, Haas RJ, Janka-Schaub G, Kühl J, Lenard HG, Rister M, Spaar HJ.
    Klin Padiatr; 1989 Feb 15; 201(4):261-8. PubMed ID: 2476584
    [Abstract] [Full Text] [Related]

  • 11. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF, Yang QY, Zhen ZJ, Xia Y, Huang ZH, Ling JY.
    Ai Zheng; 2006 Dec 15; 25(12):1529-32. PubMed ID: 17166380
    [Abstract] [Full Text] [Related]

  • 12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 13. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
    Calaminus G, Andreussi L, Garré ML, Kortmann RD, Schober R, Göbel U.
    Klin Padiatr; 1997 Mar 15; 209(4):222-7. PubMed ID: 9293454
    [Abstract] [Full Text] [Related]

  • 14. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G, Pöpping K, Hasan C, Utsch B, Jüttner J, Bode U.
    Klin Padiatr; 1998 Mar 15; 210(4):248-55. PubMed ID: 9743961
    [Abstract] [Full Text] [Related]

  • 15. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
    Göbel U, Bamberg M, Calaminus G, Gnekow AK, Herrmann HD, Lenard HG, Spaar HJ, Niethammer D, Kühl J, Harms D.
    Klin Padiatr; 1993 Mar 15; 205(4):217-24. PubMed ID: 7690863
    [Abstract] [Full Text] [Related]

  • 16. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Mar 15; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 17. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
    Hartmann JT, Gauler T, Metzner B, Gerl A, Casper J, Rick O, Horger M, Schleicher J, Derigs G, Mayer-Steinacker R, Beyer J, Kuczyk MA, Bokemeyer C, German Testicular Cancer Study Group.
    J Clin Oncol; 2007 Dec 20; 25(36):5742-7. PubMed ID: 18089869
    [Abstract] [Full Text] [Related]

  • 18. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M, Miyake H, Hara I, Muramaki M, Takenaka A, Fujisawa M.
    Hinyokika Kiyo; 2007 Dec 20; 53(12):851-6. PubMed ID: 18203521
    [Abstract] [Full Text] [Related]

  • 19. Resection of thoracic and abdominal teratoma in patients after cisplatin-based chemotherapy for germ cell tumor. Late results.
    Loehrer PJ, Mandelbaum I, Hui S, Clark S, Einhorn LH, Williams SD, Donohue JP.
    J Thorac Cardiovasc Surg; 1986 Oct 20; 92(4):676-83. PubMed ID: 3020319
    [Abstract] [Full Text] [Related]

  • 20. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C, German Testicular Cancer Study Group.
    J Clin Oncol; 2003 Nov 15; 21(22):4083-91. PubMed ID: 14568987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.